O-linked β-N-acetylglucosaminidase inhibitor attenuates β-amyloid plaque and rescues memory impairment

Chaeyoung Kim, Dong Woo Nam, Sang Yoon Park, Hyundong Song, Hyun Seok Hong, Jung Hyun Boo, Eun Sun Jung, Yoonhee Kim, Ju Yuel Baek, Kwan Soo Kim, Jin Won Cho, Inhee Mook-Jung

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Deposition of β-amyloid (Aβ) as senile plaques and disrupted glucose metabolism are two main characteristics of Alzheimer's disease (AD). It is unknown, however, how these two processes are related in AD. Here we examined the relationship between O-GlcNAcylation, which is a glucose level-dependent post-translational modification that adds O-linked β-N-acetylglucosamine (O-GlcNAc) to proteins, and Aβ production in a mouse model of AD carrying 5XFAD genes. We found that 1,2-dideoxy-2'-propyl-α- d-glucopyranoso-[2,1-d]-δ2'-thiazoline (NButGT), a specific inhibitor of O-GlcNAcase, reduces Aβ production by lowering γ-secretase activity both in vitro and in vivo. We also found that O-GlcNAcylation takes place at the S708 residue of nicastrin, which is a component of γ-secretase. Moreover, NButGT attenuated the accumulation of Aβ, neuroinflammation, and memory impairment in the 5XFAD mice. This is the first study to show the relationship between Aβ generation and O-GlcNAcylation in vivo. These results suggest that O-GlcNAcylation may be a suitable therapeutic target for the treatment of AD.

Original languageEnglish
Pages (from-to)275-285
Number of pages11
JournalNeurobiology of Aging
Volume34
Issue number1
DOIs
Publication statusPublished - 2013 Jan 1

Fingerprint

Acetylglucosaminidase
Amyloid Plaques
Alzheimer Disease
Amyloid Precursor Protein Secretases
Glucose
Acetylglucosamine
Staphylococcal Protein A
Post Translational Protein Processing
Amyloid
Genes
1,2-dideoxy-2'-propylglucopyranoso(2,1-d)-delta 2'-thiazoline
Therapeutics

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)
  • Ageing
  • Clinical Neurology
  • Developmental Biology
  • Geriatrics and Gerontology

Cite this

Kim, Chaeyoung ; Nam, Dong Woo ; Park, Sang Yoon ; Song, Hyundong ; Hong, Hyun Seok ; Boo, Jung Hyun ; Jung, Eun Sun ; Kim, Yoonhee ; Baek, Ju Yuel ; Kim, Kwan Soo ; Cho, Jin Won ; Mook-Jung, Inhee. / O-linked β-N-acetylglucosaminidase inhibitor attenuates β-amyloid plaque and rescues memory impairment. In: Neurobiology of Aging. 2013 ; Vol. 34, No. 1. pp. 275-285.
@article{bd5dcfb618d049d49d206fad159a3334,
title = "O-linked β-N-acetylglucosaminidase inhibitor attenuates β-amyloid plaque and rescues memory impairment",
abstract = "Deposition of β-amyloid (Aβ) as senile plaques and disrupted glucose metabolism are two main characteristics of Alzheimer's disease (AD). It is unknown, however, how these two processes are related in AD. Here we examined the relationship between O-GlcNAcylation, which is a glucose level-dependent post-translational modification that adds O-linked β-N-acetylglucosamine (O-GlcNAc) to proteins, and Aβ production in a mouse model of AD carrying 5XFAD genes. We found that 1,2-dideoxy-2'-propyl-α- d-glucopyranoso-[2,1-d]-δ2'-thiazoline (NButGT), a specific inhibitor of O-GlcNAcase, reduces Aβ production by lowering γ-secretase activity both in vitro and in vivo. We also found that O-GlcNAcylation takes place at the S708 residue of nicastrin, which is a component of γ-secretase. Moreover, NButGT attenuated the accumulation of Aβ, neuroinflammation, and memory impairment in the 5XFAD mice. This is the first study to show the relationship between Aβ generation and O-GlcNAcylation in vivo. These results suggest that O-GlcNAcylation may be a suitable therapeutic target for the treatment of AD.",
author = "Chaeyoung Kim and Nam, {Dong Woo} and Park, {Sang Yoon} and Hyundong Song and Hong, {Hyun Seok} and Boo, {Jung Hyun} and Jung, {Eun Sun} and Yoonhee Kim and Baek, {Ju Yuel} and Kim, {Kwan Soo} and Cho, {Jin Won} and Inhee Mook-Jung",
year = "2013",
month = "1",
day = "1",
doi = "10.1016/j.neurobiolaging.2012.03.001",
language = "English",
volume = "34",
pages = "275--285",
journal = "Neurobiology of Aging",
issn = "0197-4580",
publisher = "Elsevier Inc.",
number = "1",

}

Kim, C, Nam, DW, Park, SY, Song, H, Hong, HS, Boo, JH, Jung, ES, Kim, Y, Baek, JY, Kim, KS, Cho, JW & Mook-Jung, I 2013, 'O-linked β-N-acetylglucosaminidase inhibitor attenuates β-amyloid plaque and rescues memory impairment', Neurobiology of Aging, vol. 34, no. 1, pp. 275-285. https://doi.org/10.1016/j.neurobiolaging.2012.03.001

O-linked β-N-acetylglucosaminidase inhibitor attenuates β-amyloid plaque and rescues memory impairment. / Kim, Chaeyoung; Nam, Dong Woo; Park, Sang Yoon; Song, Hyundong; Hong, Hyun Seok; Boo, Jung Hyun; Jung, Eun Sun; Kim, Yoonhee; Baek, Ju Yuel; Kim, Kwan Soo; Cho, Jin Won; Mook-Jung, Inhee.

In: Neurobiology of Aging, Vol. 34, No. 1, 01.01.2013, p. 275-285.

Research output: Contribution to journalArticle

TY - JOUR

T1 - O-linked β-N-acetylglucosaminidase inhibitor attenuates β-amyloid plaque and rescues memory impairment

AU - Kim, Chaeyoung

AU - Nam, Dong Woo

AU - Park, Sang Yoon

AU - Song, Hyundong

AU - Hong, Hyun Seok

AU - Boo, Jung Hyun

AU - Jung, Eun Sun

AU - Kim, Yoonhee

AU - Baek, Ju Yuel

AU - Kim, Kwan Soo

AU - Cho, Jin Won

AU - Mook-Jung, Inhee

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Deposition of β-amyloid (Aβ) as senile plaques and disrupted glucose metabolism are two main characteristics of Alzheimer's disease (AD). It is unknown, however, how these two processes are related in AD. Here we examined the relationship between O-GlcNAcylation, which is a glucose level-dependent post-translational modification that adds O-linked β-N-acetylglucosamine (O-GlcNAc) to proteins, and Aβ production in a mouse model of AD carrying 5XFAD genes. We found that 1,2-dideoxy-2'-propyl-α- d-glucopyranoso-[2,1-d]-δ2'-thiazoline (NButGT), a specific inhibitor of O-GlcNAcase, reduces Aβ production by lowering γ-secretase activity both in vitro and in vivo. We also found that O-GlcNAcylation takes place at the S708 residue of nicastrin, which is a component of γ-secretase. Moreover, NButGT attenuated the accumulation of Aβ, neuroinflammation, and memory impairment in the 5XFAD mice. This is the first study to show the relationship between Aβ generation and O-GlcNAcylation in vivo. These results suggest that O-GlcNAcylation may be a suitable therapeutic target for the treatment of AD.

AB - Deposition of β-amyloid (Aβ) as senile plaques and disrupted glucose metabolism are two main characteristics of Alzheimer's disease (AD). It is unknown, however, how these two processes are related in AD. Here we examined the relationship between O-GlcNAcylation, which is a glucose level-dependent post-translational modification that adds O-linked β-N-acetylglucosamine (O-GlcNAc) to proteins, and Aβ production in a mouse model of AD carrying 5XFAD genes. We found that 1,2-dideoxy-2'-propyl-α- d-glucopyranoso-[2,1-d]-δ2'-thiazoline (NButGT), a specific inhibitor of O-GlcNAcase, reduces Aβ production by lowering γ-secretase activity both in vitro and in vivo. We also found that O-GlcNAcylation takes place at the S708 residue of nicastrin, which is a component of γ-secretase. Moreover, NButGT attenuated the accumulation of Aβ, neuroinflammation, and memory impairment in the 5XFAD mice. This is the first study to show the relationship between Aβ generation and O-GlcNAcylation in vivo. These results suggest that O-GlcNAcylation may be a suitable therapeutic target for the treatment of AD.

UR - http://www.scopus.com/inward/record.url?scp=84868101106&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868101106&partnerID=8YFLogxK

U2 - 10.1016/j.neurobiolaging.2012.03.001

DO - 10.1016/j.neurobiolaging.2012.03.001

M3 - Article

C2 - 22503002

AN - SCOPUS:84868101106

VL - 34

SP - 275

EP - 285

JO - Neurobiology of Aging

JF - Neurobiology of Aging

SN - 0197-4580

IS - 1

ER -